Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
VizionfocusTPE:4771 -0.49%91 PB Ratio is 2.98 as of Jul. 16, 2026, which is 10% below its 10-year median of 3.30. GuruFocus rates TPE:4771 with a GF Score™ of 91/100 and a GF Value™ of NT$294.76 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 787 Medical Devices & Instruments companies, Vizionfocus ranks worse than 62.9% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-16), Vizionfocus's share price is NT$203.00. Vizionfocus's Book Value per Share for the quarter that ended in Dec. 2025 was NT$68.08. Hence, Vizionfocus's PB Ratio of today is 2.98.
The historical rank and industry rank for Vizionfocus's PB Ratio or its related term are showing as below:
TPE:4771'
s PB Ratio Range Over the Past 10 Years
Min: 2.55 Med: 3.3 Max: 11.17
Current: 2.99
During the past 8 years, Vizionfocus's highest PB Ratio was 11.17. The lowest was 2.55. And the median was 3.30.
TPE:4771's PB Ratio is ranked worse than 62.9% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.05
vs TPE:4771: 2.99
During the past 12 months, Vizionfocus's average Book Value Per Share Growth Rate was 11.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 29.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 28.40% per year.
During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Vizionfocus was 53.70% per year. The lowest was 20.50% per year. And the median was 29.30% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Vizionfocus PB Ratio Related Terms
Vizionfocus PB Ratio Historical Data
* Premium members only.
The historical data trend for Vizionfocus's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Vizionfocus's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vizionfocus PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vizionfocus's PB Ratio distribution charts can be found below:
* The bar in red indicates where Vizionfocus's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Vizionfocus's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Vizionfocus (TPE:4771) has a PB Ratio of 2.98 as of Jul. 16, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Vizionfocus and its competitors. This is 10% below median its historical median of 3.30. Over the past decade, Vizionfocus' PB Ratio has ranged from 2.55 to 11.17. According to the industry distribution chart, Vizionfocus ranks #495 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 62.9%.
Is Vizionfocus' PB Ratio too high?
Vizionfocus' current PB Ratio of 2.98 is 10% below median its 10-year median of 3.30. Over the past 10 years, this metric has ranged from a low of 2.55 to a high of 11.17. The Medical Devices & Instruments industry median PB Ratio is 2.05. Vizionfocus' value of 2.98 is 45.4% above this industry median. Based on the distribution chart, Vizionfocus ranks #495 out of 787 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Vizionfocus has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vizionfocus' PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Vizionfocus ranks #495 out of 787 companies for PB Ratio. This places Vizionfocus in the lower half of its industry. The industry median PB Ratio is 2.05. Vizionfocus' value of 2.98 is 45.4% above this benchmark. Historically, Vizionfocus' own PB Ratio has ranged from 2.55 to 11.17 over the past decade. While the company's 10-year median is 3.30 vs. the industry median of 2.05, Vizionfocus has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.05, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vizionfocus's current PB Ratio of 2.98 is 45.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Vizionfocus and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vizionfocus's current PB Ratio is 2.98, which is 10% below median its own 10-year median of 3.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vizionfocus stock overvalued right now?
Based on GuruFocus' analysis, Vizionfocus (TPE:4771) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$294.76, compared to a current price of NT$203.00 — trading 31.1% below its estimated fair value. The current PB Ratio is 2.98, which is 10% below median its 10-year median of 3.30 and 45.4% above the Medical Devices & Instruments industry median of 2.05. Vizionfocus' overall GF Score™ is 91/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Vizionfocus (TPE:4771), the current PB Ratio is 2.98 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vizionfocus (TPE:4771) Overvalued in 2026?
Based on GuruFocus' analysis, Vizionfocus stock appears to be undervalued.
The current stock price of NT$203.00 is trading 31.1% below its estimated GF Value™ of NT$294.76.
GuruFocus considers Vizionfocus to be Significantly Undervalued.
Key valuation signals for TPE:4771:
PB Ratio: 2.98 (10% below median its 10-year median of 3.30)
GF Value™: NT$294.76 vs. price of NT$203.00 (31.1% below fair value)
Industry Position: 45.4% above the Medical Devices & Instruments median (#495 of 787)
No single metric tells the full story. See the TPE:4771 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vizionfocus Inc is mainly engaged in the manufacturing of medical equipment, machinery and equipment, optical instruments, precision instruments, international trading, and other consulting services. The Company operates through the VIZIONFOCUS segment, which generates maximum revenue and is engaged in the manufacturing of medical equipment, machinery and equipment, optical instruments, precision instruments, international trading, and other consulting services, and the Jiangsu Vizionfocus Inc. segment, whose main business includes the research and development, design, and production of contact lenses, as well as the wholesale, import, and export of related products.
91GF Score
Get the complete analysis for TPE:4771
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4771 has been successfully added to your 
